Abstract
One promise of recombinant DNA technology is the possibility of developing new and improved vaccines to prevent the transmission of infectious diseases. Using these techniques, it is possible to produce virtually unlimited quantities of the surface antigens of pathogenic organisms without resorting to the large-scale culture of the pathogen itself. Conventional methods of vaccine production (i.e., live attenuated viruses, killed viruses, or extracts of killed viruses) are limited by the fact that some pathogens are difficult or uneconomical to grow. In addition, society is still haunted by fears that such vaccine preparations could be contaminated by unattenuated or inadequately inactivated virus. Even when the most stringent production methods are applied, manufacturers must be concerned with the possibility that a vaccine could induce latent infections, oncogenic transformation, or autoimmunity. The recombinant DNA approach to vaccine development circumvents these problems by providing a preparation consisting of a single highly purified protein, derived from a safe noninfectious source.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexander, S., and Elder, J. H. (1984). Science 226, 1328–1330.
Allan, J., Coligan, J., Barin, F., McLane, M., Sodrowski, J., Rosen, C., Haseltine W., Lee, T., and Essex, M. (1985). Science 228, 1091–1094.
Berman, P. W., Gregory, T., Crase, D., and Lasky, L. A. (1985). Science 227, 1490–1492.
Coffin, J., Haase, A., Levy, J. A., Montagnier, L., Orosziam, S., Teick, N., Temin, H., Toyoshima, K., Varmus, H., Vogt, P., Weiss, R. (1986). Nature (Lond.) 321, 10.
Dalgleish, A. G., Beverly, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1984). Nature (Lond.) 312, 763–766.
Fauci, A., Macker, A., Longo, D., Lane, H., Rook, A., Masur, H., and Gelmann, E. (1984). Ann. Med. 100, 92–106.
Hitzman, R. A., Chen, C. Y., Hagie, F. E., Patzer, E. J., Liu, C-C, Estell, J. D., Miller, J. V., Yaffe, A., Kleid, D. G., Levinson, A. D., and Opperman, H. (1983). Nucleic Acids Res. 11, 2745–2763.
Hopp, T. P., and Woods, K. R. (1981). Proc. Natl. Acad. Sci. USA 78, 3824–3828.
Kern, E. R., Vogt, P. E., Gregory, T., Lasky, L. A., and Berman, P. W. (1987). J. Virol, (in press).
Klatzman, D., Champagne, E., Chamoret, S., Greuest, J., Guefard, D., Hercond, T., Gluckman, J. C, and Montagnier, L. (1984). Nature (Lond.) 312, 767–768.
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., and Bachrach, H. L. (1981). Science 214, 1125–1129.
Lasky, L. A., Dowbenko, D., Simonsen, C. C, and Berman, P. W. (1984). Bio /Technology 2, 527–532.
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., and Berman, P. W. (1986). Science 233, 209–212.
Muesing, M. A., Smith, D. H., Cabradilla, C. D., Benton, C. V., Lasky, L. A., and Capon, D. J. (1985). Nature (Lond.) 313, 450–458.
Paoletti, E., Lipinskas, B. R., Samsonoff, C, Mercer, S., and Panicali, D. (1984). Proc. Natl. Acad. Sci. USA 81, 193–197.
Smith, G. L., Murphy, B. R., and Moss, B. (1983). Proc. Natl. Acad. Sci. USA 80, 7155–7159.
Staal, F. W., and Gallo, R. C. (1985). Blood 65, 253–263.
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., and Hal, B. D., (1982). Nature (Lond.) 298, 347–350.
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., Sarnagadharan, M. G. (1985). Science 229, 1402–1405.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Berman, P.W., Gregory, T., Dowbenko, D., Lasky, L.A. (1988). Production of Viral Glycoproteins in Genetically Engineered Mammalian Cell Lines for Use as Vaccines against Herpes Simplex Virus and the Acquired Immune Deficiency Syndrome Retrovirus. In: Kurstak, E., Marusyk, R.G., Murphy, F.A., Van Regenmortel, M.H.V. (eds) New Vaccines and Chemotherapy. Applied Virology Research, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9268-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9268-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9270-6
Online ISBN: 978-1-4757-9268-3
eBook Packages: Springer Book Archive